Drug Shortage Report for APO-PERINDOPRIL-INDAPAMIDE

Last updated on 2023-09-15 History
Report ID 186580
Drug Identification Number 02453061
Brand name APO-PERINDOPRIL-INDAPAMIDE
Common or Proper name PERIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) PERINDOPRIL ERBUMINE INDAPAMIDE
Strength(s) 8MG 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-07
Estimated end date 2023-09-22
Actual end date 2022-09-14
Shortage status Avoided shortage
Updated date 2023-09-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-03-09 English Compare
v2 2023-03-09 French Compare
v3 2023-03-16 English Compare
v4 2023-03-16 French Compare
v5 2023-04-06 English Compare
v6 2023-04-06 French Compare
v7 2023-04-27 English Compare
v8 2023-04-27 French Compare
v9 2023-05-26 English Compare
v10 2023-05-26 French Compare
v11 2023-06-02 English Compare
v12 2023-06-02 French Compare
v13 2023-06-23 English Compare
v14 2023-06-23 French Compare
v15 2023-06-29 English Compare
v16 2023-06-29 French Compare
v17 2023-07-07 English Compare
v18 2023-07-07 French Compare
v19 2023-07-13 English Compare
v20 2023-07-13 French Compare

Showing 1 to 20 of 30